Park SB - Search Results

1

Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy.

Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC. Park SB, et al. Exp Neurol. 2011 Jan;227(1):120-7. doi: 10.1016/j.expneurol.2010.10.002. Epub 2010 Oct 20. Exp Neurol. 2011. PMID: 20965170

2

Assessment of nerve excitability in toxic and metabolic neuropathies.

Krishnan AV, Lin CS, Park SB, Kiernan MC. Krishnan AV, et al. Among authors: park sb. J Peripher Nerv Syst. 2008 Mar;13(1):7-26. doi: 10.1111/j.1529-8027.2008.00155.x. J Peripher Nerv Syst. 2008. PMID: 18346228 Review.

3

Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.

Park SB, Krishnan AV, Lin CS, Goldstein D, Friedlander M, Kiernan MC. Park SB, et al. Curr Med Chem. 2008;15(29):3081-94. doi: 10.2174/092986708786848569. Curr Med Chem. 2008. PMID: 19075655 Review.

4

Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.

Park SB, Goldstein D, Lin CS, Krishnan AV, Friedlander ML, Kiernan MC. Park SB, et al. J Clin Oncol. 2009 Mar 10;27(8):1243-9. doi: 10.1200/JCO.2008.19.3425. Epub 2009 Jan 21. J Clin Oncol. 2009. PMID: 19164207

5

Axonal ion channels from bench to bedside: a translational neuroscience perspective.

Krishnan AV, Lin CS, Park SB, Kiernan MC. Krishnan AV, et al. Among authors: park sb. Prog Neurobiol. 2009 Nov;89(3):288-313. doi: 10.1016/j.pneurobio.2009.08.002. Epub 2009 Aug 21. Prog Neurobiol. 2009. PMID: 19699774 Review.

6

Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.

Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC. Park SB, et al. Brain. 2009 Oct;132(Pt 10):2712-23. doi: 10.1093/brain/awp219. Epub 2009 Sep 10. Brain. 2009. PMID: 19745023

7

Oxaliplatin-induced lhermitte's phenomenon as a manifestation of severe generalized neurotoxicity.

Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC. Park SB, et al. Oncology. 2009;77(6):342-8. doi: 10.1159/000265940. Epub 2009 Dec 14. Oncology. 2009. PMID: 20016227

8

Regional differences in ulnar nerve excitability may predispose to the development of entrapment neuropathy.

Krishnan AV, Park SB, Payne M, Lin CS, Vucic S, Kiernan MC. Krishnan AV, et al. Among authors: park sb. Clin Neurophysiol. 2011 Jan;122(1):194-8. doi: 10.1016/j.clinph.2010.04.038. Epub 2010 Jun 29. Clin Neurophysiol. 2011. PMID: 20591727

9

Acute, reversible axonal energy failure during stroke-like episodes in MELAS.

Farrar MA, Lin CS, Krishnan AV, Park SB, Andrews PI, Kiernan MC. Farrar MA, et al. Among authors: park sb. Pediatrics. 2010 Sep;126(3):e734-9. doi: 10.1542/peds.2009-2930. Epub 2010 Aug 2. Pediatrics. 2010. PMID: 20679297

10

Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy.

Park SB, Lin CS, Krishnan AV, Friedlander ML, Lewis CR, Kiernan MC. Park SB, et al. Muscle Nerve. 2011 Mar;43(3):367-74. doi: 10.1002/mus.21874. Epub 2010 Dec 9. Muscle Nerve. 2011. PMID: 21321953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,706 results

Search Page

Filters